Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease.

Alzheimers Res Ther · 2025 · PMC11702188 · PMID 39762936

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Aβ 25-35 -treated mice receiving vehicle solution in the pump showed a highly significant deficit as compared with V/V-treated animals or untreated controls (Fig. 1 b).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.